These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23645677)

  • 1. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).
    Chiluiza D; Krishna S; Schumacher VA; Schlöndorff J
    J Biol Chem; 2013 Jun; 288(25):18407-20. PubMed ID: 23645677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
    Yu M; Hu J; Ju T; Wang R; Wang M; Gao C; Xia Z
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):284-288. PubMed ID: 38814201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPC6 G757D Loss-of-Function Mutation Associates with FSGS.
    Riehle M; Büscher AK; Gohlke BO; Kaßmann M; Kolatsi-Joannou M; Bräsen JH; Nagel M; Becker JU; Winyard P; Hoyer PF; Preissner R; Krautwurst D; Gollasch M; Weber S; Harteneck C
    J Am Soc Nephrol; 2016 Sep; 27(9):2771-83. PubMed ID: 26892346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
    Kim EY; Roshanravan H; Dryer SE
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5.
    Polat OK; Isaeva E; Sudhini YR; Knott B; Zhu K; Noben M; Suresh Kumar V; Endlich N; Mangos S; Reddy TV; Samelko B; Wei C; Altintas MM; Dryer SE; Sever S; Staruschenko A; Reiser J
    Kidney Int; 2023 Jun; 103(6):1056-1062. PubMed ID: 36750145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Arrestin pathway activation by selective ATR1 agonism promotes calcium influx in podocytes, leading to glomerular damage.
    Semenikhina M; Fedoriuk M; Stefanenko M; Klemens CA; Cherezova A; Marshall B; Hall G; Levchenko V; Solanki AK; Lipschutz JH; Ilatovskaya DV; Staruschenko A; Palygin O
    Clin Sci (Lond); 2023 Dec; 137(24):1789-1804. PubMed ID: 38051199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klotho May Ameliorate Proteinuria by Targeting TRPC6 Channels in Podocytes.
    Kim JH; Xie J; Hwang KH; Wu YL; Oliver N; Eom M; Park KS; Barrezueta N; Kong ID; Fracasso RP; Huang CL; Cha SK
    J Am Soc Nephrol; 2017 Jan; 28(1):140-151. PubMed ID: 27151926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy.
    Hofstra JM; Coenen MJ; Schijvenaars MM; Berden JH; van der Vlag J; Hoefsloot LH; Knoers NV; Wetzels JF; Nijenhuis T
    PLoS One; 2014; 9(7):e102065. PubMed ID: 25019165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serine 814 of TRPC6 is phosphorylated under unstimulated conditions.
    Bousquet SM; Monet M; Boulay G
    PLoS One; 2011 Mar; 6(3):e18121. PubMed ID: 21448286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
    Zhou Y; Castonguay P; Sidhom EH; Clark AR; Dvela-Levitt M; Kim S; Sieber J; Wieder N; Jung JY; Andreeva S; Reichardt J; Dubois F; Hoffmann SC; Basgen JM; Montesinos MS; Weins A; Johnson AC; Lander ES; Garrett MR; Hopkins CR; Greka A
    Science; 2017 Dec; 358(6368):1332-1336. PubMed ID: 29217578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK1702934A and M085 directly activate TRPC6 via a mechanism of stimulating the extracellular cavity formed by the pore helix and transmembrane helix S6.
    Yang PL; Li XH; Wang J; Ma XF; Zhou BY; Jiao YF; Wang WH; Cao P; Zhu MX; Li PW; Xiao ZH; Li CZ; Guo CR; Lei YT; Yu Y
    J Biol Chem; 2021 Oct; 297(4):101125. PubMed ID: 34461094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the S100A1 protein binding site on TRPC6 C-terminus.
    Bily J; Grycova L; Holendova B; Jirku M; Janouskova H; Bousova K; Teisinger J
    PLoS One; 2013; 8(5):e62677. PubMed ID: 23671622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired apoptosis in lymphoblasts from Alzheimer's disease patients: cross-talk of Ca2+/calmodulin and ERK1/2 signaling pathways.
    Bartolomé F; de Las Cuevas N; Muñoz U; Bermejo F; Martín-Requero A
    Cell Mol Life Sci; 2007 Jun; 64(11):1437-48. PubMed ID: 17502994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPC6 is ubiquitously present in lymphatic tissues: A study using samples from body donors.
    Daum F; Flockerzi F; Bozzato A; Schick B; Tschernig T
    Med Int (Lond); 2024; 4(6):62. PubMed ID: 39161881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-glucose-sensitive TRPC6 dysfunction drives hypoglycemia-induced cognitive impairment in diabetes.
    He C; Gao P; Cui Y; Li Q; Li Y; Lu Z; Ma H; Zhao Y; Li L; Sun F; Chen X; Jia H; Liu D; Yang G; Zheng H; Zhu Z
    Clin Transl Med; 2020 Oct; 10(6):e205. PubMed ID: 33135341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCC0208057 as a small molecule inhibitor of TRPC6 in the treatment of prostate cancer.
    Wei Y; Li M; Hu Y; Lu J; Wang L; Yin Q; Hong X; Tian J; Wang H
    Front Pharmacol; 2024; 15():1352373. PubMed ID: 38567350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6.
    Ramirez GA; Coletto LA; Sciorati C; Bozzolo EP; Manunta P; Rovere-Querini P; Manfredi AA
    Cells; 2018 Jul; 7(7):. PubMed ID: 29973568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and accessibility studies highlight the differential binding of clemizole to TRPC5 and TRPC6.
    Saqib U; Demaree IS; Obukhov AG; Baig MS; Khan MS; Altwaijry N; Nasution MAF; Mizuguchi K; Hajela K
    J Biomol Struct Dyn; 2024 Jan; ():1-14. PubMed ID: 38279926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase C epsilon (PLCε) induced TRPC6 activation: a common but redundant mechanism in primary podocytes.
    Kalwa H; Storch U; Demleitner J; Fiedler S; Mayer T; Kannler M; Fahlbusch M; Barth H; Smrcka A; Hildebrandt F; Gudermann T; Dietrich A
    J Cell Physiol; 2015 Jun; 230(6):1389-99. PubMed ID: 25521631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
    J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.